PROVIDER PROFILE · NPI 1780620823

Ronald ChioMD

Internal MedicineEuless, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,141

Unique beneficiaries

—

Total services

1,304

Distinct HCPCS

Medicare payment

$88K

Peer benchmark

Total Medicare services vs. 6,183 Internal Medicine providers in TX — top quintile (cohort median 673).

PRESCRIBING · PART D · 2024

Total Rx claims

11,533

Beneficiaries

—

Total drug cost

$741K

Distinct drugs

157

Brand share

18.3%

Top prescribed drugs

Levothyroxine Sodium804 claims

Atorvastatin Calcium623 claims

Rosuvastatin Calcium551 claims

Amlodipine Besylate440 claims

Losartan Potassium376 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

104

By payment type

Food and Beverage$2K

Top paying entities

Food and Beverage$2K

REFERRAL NETWORK

Where Ronald Chio's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	152	409
TEXAS HEALTH HARRIS METHODIST HOSPITAL HURST-EULESS-BEDFORD	96	272
BTDI JV LLP	36	73
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	20	44
David Martin Nephrology · Euless, TX	12	42
Lance Driskill Diagnostic Radiology · Plano, TX	12	33

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history